Retatrutide has not received Health Canada approval and remains in Phase 3 clinical trials globally
Her goal was to break free from the frustrating cycle of weight gain, which persisted despite her efforts to stick to healthy eating habits during the day
Most women normalize within three to six months, even if they continue losing weight
Drug Resistance When weight-loss medications fail to deliver results, users may opt for stronger, more potent drugs, leading to drug resistance
Emerging evidence demonstrates that GLP-1 receptors are expressed in Type II taste cells, where they modulate sweet sensitivity through the G-gustducin/TRPM5 pathway, and downregulate T1R2/T1R3 expression and ATP release (164, 165)
One mouse and one datapoint in vehicle group was omitted from analysis as they had insulin levels outside the assay range